about
A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinomaKPT-330 inhibitor of XPO1-mediated nuclear export has anti-proliferative activity in hepatocellular carcinoma.Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literatureGene signatures of drug resistance predict patient survival in colorectal cancerThe role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysisFoxM1 transactivates PTTG1 and promotes colorectal cancer cell migration and invasionBelinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancerSorafenib therapy following resection prolongs disease-free survival in patients with advanced hepatocellular carcinoma at a high risk of recurrence.CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter Study.Resection versus ablation in hepatitis B virus-related hepatocellular carcinoma patients with portal hypertension: A propensity score matching study.Hepatic resection for synchronous hepatic metastasis from gastric cancer.Nomogram to Predict Survival of Patients with Recurrence of Hepatocellular Carcinoma After Surgery.Percutaneous microwave ablation of larger hepatocellular carcinoma.Hepatocellular carcinoma treated with radiofrequency ablation with or without ethanol injection: a prospective randomized trialEfficacy and safety of thermal ablation in patients with liver metastasesHepatectomy Versus Hepatectomy With Lymphadenectomy in Hepatocellular Carcinoma: A Prospective, Randomized Controlled Clinical TrialResection vs. ablation for alpha-fetoprotein positive hepatocellular carcinoma within the Milan criteria: a propensity score analysisMicrowave ablation versus resection for hepatocellular carcinoma within the Milan criteria: a propensity-score analysisMicrowave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysisComparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy
P50
Q24544663-A3775AD7-38DE-439A-9E30-07F52A0AACD7Q34098446-69E0F561-AC53-4350-9140-B22FBE6F4140Q34517592-081B29F3-F68D-48B6-80D5-65C78541E76DQ35237150-68D1AD32-8603-4CE7-A5CA-198CA0242AABQ35441132-8045AAEA-5BD0-4A81-8991-5577766DDE61Q35743041-9D0B2A69-9FA9-4BB5-B47D-956A532E8298Q37092508-A3CFD8A0-92BA-4873-A066-3AEB5EB07CBFQ37701106-E6F693BE-6CD4-4BA2-983C-5A20C5784305Q40389253-FBFE1F64-0BDA-4527-85A8-59B984D4EF39Q41750292-44E760DF-9346-40D7-9A30-2492D92AC568Q45383669-E05499FC-4FB8-4ACC-B911-91563FAC7289Q47191908-D3CC6EF2-8490-4ABB-B2DB-7EEA40860BBEQ53153527-6C194D7D-9B02-46A1-B3FE-1D3799738FE2Q56785995-F58A9315-7568-495E-8B2E-A3691AA8BA3AQ86307530-5C38E244-F353-404E-A4DC-9520519B63C7Q86485800-E88E7D97-C633-47EB-AFB3-5D978E30AAF6Q89215444-79ECE16B-ADB0-411F-9589-2ADFBBCEBCE8Q90532946-709CA4CD-E3CF-419D-8765-43FAB3F88410Q90659238-DC50FA08-9F88-4E12-8608-6B13C379FD5DQ90943573-A80A916F-C4DE-4F54-A097-CC15C744A159
P50
description
researcher ORCID ID = 0000-0001-6717-3959
@en
name
Yun Zheng
@ast
Yun Zheng
@en
Yun Zheng
@es
Yun Zheng
@nl
type
label
Yun Zheng
@ast
Yun Zheng
@en
Yun Zheng
@es
Yun Zheng
@nl
prefLabel
Yun Zheng
@ast
Yun Zheng
@en
Yun Zheng
@es
Yun Zheng
@nl
P1153
55617479900
P31
P496
0000-0001-6717-3959